엠디웍스코리아

Skip to main content Skip to main menu

Quality Management

Re-evaluation & Post-Market Surveillance (Re-examination)

Re-evaluation overview

Re-evaluation

Because not all safety and effectiveness information for innovative or rare medical devices can be obtained from limited data at the time of approval, factors affecting safety and effectiveness are investigated and verified in a broad patient population after approval and reflected in the approved labeling to enable efficient management.

Legal basis

Medical Devices Act

Enforcement Rules of the Medical Devices Act

Regulations on Re-evaluation of Medical Devices

Re-evaluation subjects and procedure

Subject to re-evaluation

Among medical devices with a manufacturing (import) license or notification, devices for which the Commissioner of the Ministry of Food and Drug Safety (MFDS) determines that safety and effectiveness should be reassessed.

Exclusions
  • ① Devices within a re-examination period
  • ② Devices withdrawn or cancelled during the re-evaluation period
  • ③ Devices licensed or notified solely for export

STEP 01

Selection and notice of re-evaluation subjects

From 1 to 3 years before the re-evaluation application date

STEP 02

Determination and public notice of re-evaluation products

STEP 03

Re-evaluation application

Within the re-evaluation application period

STEP 04

Conduct of re-evaluation and draft preparation

STEP 05

Public inspection

One month from the date of public notice

STEP 06

Submission of comments

STEP 07

Finalization and public notice of re-evaluation results

According to the schedule announced by the MFDS after review

STEP 08

Follow-up measures

Within 1–2 months from the date of public notice

Re-examination (post-market surveillance) overview

Purpose

Because not all safety and effectiveness information for innovative or rare medical devices can be obtained from limited data at the time of approval, factors affecting safety and effectiveness are investigated and verified in a broad patient population after approval and reflected in the approved labeling to enable efficient management.

Legal basis

Medical Devices Act

Enforcement Rules of the Medical Devices Act

Regulations on Post-Market Surveillance of Medical Devices

Subjects and procedure

Products subject to post-market surveillance

Products classified as innovative or rare medical devices for which the Commissioner of the MFDS determines that post-market surveillance of safety and effectiveness is necessary.

Post-market surveillance procedure
Diagram of the post-market surveillance procedure